153 related articles for article (PubMed ID: 38439530)
21. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
[TBL] [Abstract][Full Text] [Related]
22. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
Taketomi A; Sanefuji K; Soejima Y; Yoshizumi T; Uhciyama H; Ikegami T; Harada N; Yamashita Y; Sugimachi K; Kayashima H; Iguchi T; Maehara Y
Transplantation; 2009 Feb; 87(4):531-7. PubMed ID: 19307789
[TBL] [Abstract][Full Text] [Related]
23. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
24. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Aishima S; Terashi T; Shimada M; Maehara Y
Transplantation; 2007 Apr; 83(7):893-9. PubMed ID: 17460559
[TBL] [Abstract][Full Text] [Related]
25. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study.
Azoulay D; Audureau E; Bhangui P; Belghiti J; Boillot O; Andreani P; Castaing D; Cherqui D; Irtan S; Calmus Y; Chazouillères O; Soubrane O; Luciani A; Feray C
Ann Surg; 2017 Dec; 266(6):1035-1044. PubMed ID: 27617853
[TBL] [Abstract][Full Text] [Related]
26. Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation.
Na GH; Hong TH; You YK; Kim DG
World J Gastroenterol; 2016 Jul; 22(25):5790-9. PubMed ID: 27433092
[TBL] [Abstract][Full Text] [Related]
27. Donor sex and donor-recipient sex disparity do not affect hepatocellular carcinoma recurrence after living donor liver transplantation.
Oh RK; Hwang S; Song GW; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Yoon YI; Kang WH
Ann Surg Treat Res; 2023 Sep; 105(3):133-140. PubMed ID: 37693289
[TBL] [Abstract][Full Text] [Related]
28. Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis.
Grant RC; Sandhu L; Dixon PR; Greig PD; Grant DR; McGilvray ID
Clin Transplant; 2013; 27(1):140-7. PubMed ID: 23157398
[TBL] [Abstract][Full Text] [Related]
29. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation.
Na GH; Kim DG; Han JH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Jun; 20(21):6594-601. PubMed ID: 24914382
[TBL] [Abstract][Full Text] [Related]
31. Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma Within or Beyond the Milan Criteria: Comparable Long-Term Outcomes.
Lee S; Song GW; Kim KW; Kwon JH; Lee SG
Transplant Proc; 2021; 53(1):92-97. PubMed ID: 33288309
[TBL] [Abstract][Full Text] [Related]
32. Quantitative Prediction of Posttransplant Hepatocellular Carcinoma Prognosis Using ADV Score: Validation with Korea-Nationwide Transplantation Registry Database.
Park GC; Hwang S; You YK; Choi Y; Kim JM; Joo DJ; Ryu JH; Choi D; Kim BW; Kim DS; Nah YW; Kang KJ; Cho JY; Yu HC; Kim DG
J Gastrointest Surg; 2023 Jul; 27(7):1353-1366. PubMed ID: 37039979
[TBL] [Abstract][Full Text] [Related]
33. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.
Shindoh J; Sugawara Y; Nagata R; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Kokudo N
Transpl Int; 2014 Apr; 27(4):391-8. PubMed ID: 24472068
[TBL] [Abstract][Full Text] [Related]
34. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
35. Inflammation-based Prognostic Score in Patients with Living Donor Liver Transplantation for Hepatocellular Carcinoma.
Harimoto N; Yoshizumi T; Shimagaki T; Nagatsu A; Motomura T; Harada N; Okabe H; Itoh S; Ikegami T; Uchiyama H; Soejima Y; Maehara Y
Anticancer Res; 2016 Oct; 36(10):5537-5542. PubMed ID: 27798927
[TBL] [Abstract][Full Text] [Related]
36. Living Donor Liver Transplantation for Hepatocellular Carcinoma within Milan Criteria in the Present Era.
Yoshizumi T; Harimoto N; Itoh S; Okabe H; Kimura K; Uchiyama H; Ikegami T; Ikeda T; Maehara Y
Anticancer Res; 2016 Jan; 36(1):439-45. PubMed ID: 26722079
[TBL] [Abstract][Full Text] [Related]
37. An Analysis of 10,000 Cases of Living Donor Liver Transplantation in Japan: Special Reference to the Graft-Versus-Recipient Weight Ratio and Donor Age.
Eguchi S; Umeshita K; Soejima Y; Eguchi H; Egawa H; Fukumoto T; Haga H; Hasegawa K; Kasahara M; Nagano H; Takada Y; Tokushige K; Ueda Y; Mochida S; Matsushima H; Adachi T; Ohdan H;
Ann Surg; 2024 Jan; 279(1):94-103. PubMed ID: 38112092
[TBL] [Abstract][Full Text] [Related]
38. Expansion of the criteria for living donor liver transplantation for hepatocellular carcinoma.
Lee HW; Suh KS
Curr Opin Organ Transplant; 2016 Apr; 21(2):231-7. PubMed ID: 26918880
[TBL] [Abstract][Full Text] [Related]
39. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
[TBL] [Abstract][Full Text] [Related]
40. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
